| Name | Title | Contact Details |
|---|
ADVANCED PRODUCT TECHNOLOGY is a Rochester, IL-based company in the Business Services sector.
At SRA we combine our creativity, mission experience, technology acumen and domain expertise to deliver innovative IT solutions and professional services in support of the toughest mission and operational challenges of the U.S. government. We are inspired by our customers` missions and provide the best people, working together to generate the best ideas, to deliver the best possible performance - all driven by our enduring values of Honesty and Service®. SRA was founded in 1978 and employs over 5,500 professionals who are passionate about creating innovative solutions that help solve some of the most complex challenges in national and homeland security, counterterrorism and intelligence, law enforcement, energy, the environment, health, veterans affairs, agriculture, commerce, transportation and beyond.
Ronsin Photocopy is a Walnut, CA-based company in the Business Services sector.
Altick & Corwin Company LPA is a Dayton, OH-based company in the Business Services sector.
InnoCare Pharma is a commercial stage biopharmaceutical company dedicated to discovering, developing, and commercializing best-in-class and/or first-in-class drugs for the treatment of cancer and autoimmune diseases. InnoCare has strong in-house innovation capabilities, holding multiple foreign and domestic patents with a rich product pipeline target liquid tumors, solid tumors, and autoimmune diseases. Our team has discovered and developed a strong pipeline. InnoCare was co-founded by Professor Shi Yigong, a world-renowned structural biologist, and Dr. Cui Jisong, an outstanding leader in the biopharmaceutical industry. We have over 1000 employees. Our core R&D staff brings rich experience from the worlds top pharmaceutical companies, such as Pfizer, GSK, Bristol-Myers Squibb, Merck, Johnson & Johnson, Bayer, etc. We are a truly global biopharmaceutical company with sites in Beijing, Nanjing, Shanghai, and Guangzhou, Hong Kong and Unites States. On March 23, 2020, InnoCare officially listed on the Hong Kong Stock Exchange (code: 9969). And on Sept. 21, 2023, InnoCare successfully got listed on STAR Board of Shanghai Stock Exchange (code: 688428). Our vision is to become a world-class biopharma leader to address the unmet medical needs globally.